DNA topoisomerase II alpha activates cell cycle progression from the G2 to the M phase by inhibiting CHK1 phosphorylation [43] (CHK1, checkpoint kinase 1, is the protein product of the CHEK1 gene), promoting the epithelial-to-mesenchymal transition and cancer cell invasion. Here, CHEK1 is linked to cancer.